Solid Biosciences Inc (SLDB)
10.43
+0.46
(+4.61%)
USD |
NASDAQ |
May 07, 16:00
10.43
0.00 (0.00%)
After-Hours: 18:43
Solid Biosciences Cash from Operations (TTM): -94.18M for Dec. 31, 2023
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -94.18M |
September 30, 2023 | -107.84M |
June 30, 2023 | -110.37M |
March 31, 2023 | -98.78M |
December 31, 2022 | -97.98M |
September 30, 2022 | -84.37M |
June 30, 2022 | -82.37M |
March 31, 2022 | -83.59M |
December 31, 2021 | -77.76M |
September 30, 2021 | -55.58M |
June 30, 2021 | -52.72M |
March 31, 2021 | -48.69M |
December 31, 2020 | -56.60M |
Date | Value |
---|---|
September 30, 2020 | -79.15M |
June 30, 2020 | -82.83M |
March 31, 2020 | -96.06M |
December 31, 2019 | -92.71M |
September 30, 2019 | -92.87M |
June 30, 2019 | -88.92M |
March 31, 2019 | -78.95M |
December 31, 2018 | -70.20M |
September 30, 2018 | -62.78M |
June 30, 2018 | -56.92M |
March 31, 2018 | -50.20M |
December 31, 2017 | -43.22M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-110.37M
Minimum
Jun 2023
-48.69M
Maximum
Mar 2021
-83.34M
Average
-84.37M
Median
Sep 2022
Cash from Operations (TTM) Benchmarks
Sarepta Therapeutics Inc | -533.67M |
PTC Therapeutics Inc | -58.17M |
Capricor Therapeutics Inc | -25.60M |
Perspective Therapeutics Inc | -36.91M |
Electromed Inc | 4.872M |